Large-Cell Immunoblastic LymphomaSymptoms, Doctors, Treatments, Advances & More
Large-Cell Immunoblastic Lymphoma Overview
Learn About Large-Cell Immunoblastic Lymphoma
- Lymphoma, large-cell, immunoblastic
- Large cell immunoblastic lymphoma
Ballad Health Cancer Center
. Dr. Shipstone is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia. Dr. Shipstone is board certified in American Board Of Internal Medicine.
Providence Regional Cancer System - Aberdeen
Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma. Dr. Sui is board certified in American Board Of Internal Medicine. Dr. Sui is currently accepting new patients.
Alex Herrera, M.D.
Alex Herrera is an Oncologist practicing medicine in Duarte, California. He has been practicing medicine for over 17 years. Dr. Herrera is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Herrera is board certified in American Board Of Internal Medicine, Hematology and American Board Of Internal Medicine, Oncology.
Summary: This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab in treating patients with multiple myeloma, acute myeloid leukemia or lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). VSV-IFNβ-NIS is a modified vers...
Summary: This first-in-human trial will assess the safety, feasibility, and efficacy of an immunotherapy with a novel CD30 antibody conjugated to a CD3 antibody that is preloaded onto a patient's own T-cells, generating a CD30 bispecific antibody-armed, anti-CD3-activated, autologous T-cells (CD30 biAb-AATC).
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


